
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Global simultaneous development is becoming more necessary as the cost of developing medical products continues to grow. The strategy of using multiregional clinical trials (MRCTs) has become the preferred method for developing new medicines. Implementing the same protocol to include subjects from many geographical regions around the world, MRCTs can speed up the patient enrolment, thus resulting in quicker drug development and obtaining faster approval of the drug globally. After the publication of the editors' first volume on this topic, there have been new developments on MRCTs. The International Council for Harmonisation (ICH) issued ICH E17, a guideline document on MRCTs, in November 2017, laying out principles on MRCTs. Beyond E17, new methodologies have been developed as well. Simultaneous Global New Drug Development: Multi-Regional Clinical Trials after ICH E17 collects chapters providing interpretations of principles in ICH E17 and new ideas of implementing MRCTs. Authors are from different regions, and from academia and industry. In addition, in contrast to the first book, new perspectives are brought to MRCT from regulatory agencies. This book will be of particular interest to biostatisticians working in late stage clinical development of medical products. It will also be especially helpful for statisticians in regulatory agencies, and medical research institutes. This book is comprehensive across the MRCT topic spectrum, including Issues regarding ICH E17 Implementation MRCT Design and Analysis Methodologies Perspectives from authorities in regulatory agencies, as well as statisticians practicing in the medical product industry Many examples of real-life applications based on actual MRCTs
The increasing cost of medical product development necessitates global simultaneous development strategies, with multi-regional clinical trials (MRCTs) emerging as the preferred method. This book explores the implementation of MRCTs, a strategy that uses a single protocol across diverse geographical regions to expedite patient enrollment, accelerate drug development, and secure faster global approval. It addresses the principles outlined in the International Council for Harmonisation (ICH) E17 guideline, published in 2017, and presents new methodologies and perspectives on MRCTs. The content is contributed by authors from academia and industry across various regions, including new insights from regulatory agencies.
This book is designed for biostatisticians involved in late-stage clinical development, as well as statisticians in regulatory agencies and medical research institutes. The collection of chapters provides a comprehensive overview of MRCTs, covering implementation issues, design, and analysis methodologies. It incorporates insights from various global regions and includes perspectives from both industry and regulatory bodies. The inclusion of real-life application examples enhances its practical value for professionals in the field.
Page Count:
302
Publication Date:
2021-12-01
Publisher:
CRC Press, Taylor & Francis Group
ISBN-10:
1003109780
ISBN-13:
9781003109785
No comments yet. Be the first to share your thoughts!